BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33693866)

  • 21. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: Features of gut microbiome-liver-adipose tissue axis.
    Romualdo GR; Valente LC; Sprocatti AC; Bacil GP; de Souza IP; Rodrigues J; Rodrigues MAM; Vinken M; Cogliati B; Barbisan LF
    Nutrition; 2022; 103-104():111836. PubMed ID: 36202025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depletion of the gut microbiota differentially affects the impact of whey protein on high-fat diet-induced obesity and intestinal permeability.
    Boscaini S; Cabrera-Rubio R; Golubeva A; Nychyk O; Fülling C; Speakman JR; Cotter PD; Cryan JF; Nilaweera KN
    Physiol Rep; 2021 Jun; 9(11):e14867. PubMed ID: 34057306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
    Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X
    Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liraglutide modulates gut microbiota and reduces NAFLD in obese mice.
    Moreira GV; Azevedo FF; Ribeiro LM; Santos A; Guadagnini D; Gama P; Liberti EA; Saad M; Carvalho C
    J Nutr Biochem; 2018 Dec; 62():143-154. PubMed ID: 30292107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy.
    Qiu J; Chen L; Zhang L; Xu F; Zhang C; Ren G; Chang K; He G; Du Z; Le Y; Yu Z; Li S; Liu Q; Dou X
    Phytomedicine; 2023 Dec; 121():155111. PubMed ID: 37804819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of the fecal microbiome and metabolome by resistant dextrin ameliorates hepatic steatosis and mitochondrial abnormalities in mice.
    Zhang Z; Chen X; Cui B
    Food Funct; 2021 May; 12(10):4504-4518. PubMed ID: 33885128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota induces hepatic steatosis by modulating the T cells balance in high fructose diet mice.
    Zhou X; Zhang X; Niu D; Zhang S; Wang H; Zhang X; Nan F; Jiang S; Wang B
    Sci Rep; 2023 Apr; 13(1):6701. PubMed ID: 37095192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
    Komiya C; Tsuchiya K; Shiba K; Miyachi Y; Furuke S; Shimazu N; Yamaguchi S; Kanno K; Ogawa Y
    PLoS One; 2016; 11(3):e0151511. PubMed ID: 26977813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Punicalagin Prevents Hepatic Steatosis through Improving Lipid Homeostasis and Inflammation in Liver and Adipose Tissue and Modulating Gut Microbiota in Western Diet-Fed Mice.
    Liu H; Zhan Q; Miao X; Xia X; Yang G; Peng X; Yan C
    Mol Nutr Food Res; 2021 Feb; 65(4):e2001031. PubMed ID: 33369197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consumption of Walnuts in Combination with Other Whole Foods Produces Physiologic, Metabolic, and Gene Expression Changes in Obese C57BL/6J High-Fat-Fed Male Mice.
    Luo T; Miranda-Garcia O; Adamson A; Hamilton-Reeves J; Sullivan DK; Kinchen JM; Shay NF
    J Nutr; 2016 Sep; 146(9):1641-50. PubMed ID: 27489005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal sucralose intake alters gut microbiota of offspring and exacerbates hepatic steatosis in adulthood.
    Dai X; Guo Z; Chen D; Li L; Song X; Liu T; Jin G; Li Y; Liu Y; Ajiguli A; Yang C; Wang B; Cao H
    Gut Microbes; 2020 Jul; 11(4):1043-1063. PubMed ID: 32228300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
    de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
    Front Immunol; 2019; 10():2926. PubMed ID: 31998283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal Dietary Ferulic Acid for Suppressing the Obesity-Related Disorders in Leptin-Deficient Obese C57BL/6J -ob/ob Mice.
    Wang W; Pan Y; Wang L; Zhou H; Song G; Wang Y; Liu J; Li A
    J Agric Food Chem; 2019 Apr; 67(15):4250-4258. PubMed ID: 30907082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indole supplementation ameliorates MCD-induced NASH in mice.
    Zhu B; Li H; Lu B; Guo X; Wu C; Wang F; Li Q; Xie L; Glaser S; Francis H; Alpini G; Wu C
    J Nutr Biochem; 2022 Sep; 107():109041. PubMed ID: 35568098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models.
    Ahmad A; Ali T; Kim MW; Khan A; Jo MH; Rehman SU; Khan MS; Abid NB; Khan M; Ullah R; Jo MG; Kim MO
    Metabolism; 2019 Jan; 90():31-43. PubMed ID: 30473057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anhedonia induced by high-fat diet in mice depends on gut microbiota and leptin.
    Hassan AM; Mancano G; Kashofer K; Liebisch G; Farzi A; Zenz G; Claus SP; Holzer P
    Nutr Neurosci; 2022 Feb; 25(2):299-312. PubMed ID: 32290785
    [No Abstract]   [Full Text] [Related]  

  • 39. INT-767 improves histopathological features in a diet-induced
    Roth JD; Feigh M; Veidal SS; Fensholdt LK; Rigbolt KT; Hansen HH; Chen LC; Petitjean M; Friley W; Vrang N; Jelsing J; Young M
    World J Gastroenterol; 2018 Jan; 24(2):195-210. PubMed ID: 29375205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatoprotective effect of curcumin against bisphenol A-induced hepatic steatosis via modulating gut microbiota dysbiosis and related gut-liver axis activation in CD-1 mice.
    Hong T; Jiang X; Zou J; Yang J; Zhang H; Mai H; Ling W; Feng D
    J Nutr Biochem; 2022 Nov; 109():109103. PubMed ID: 35780999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.